Application of an Accessible Interface for Pharmacokinetic Modeling and In Vitro to In Vivo Extrapolation

被引:16
作者
Hines, David E.
Bell, Shannon
Chang, Xiaoqing
Mansouri, Kamel
Allen, David
Kleinstreuer, Nicole
机构
[1] Inotiv-RTP, Durham, Research Triangle Park, NC
[2] NIH/NIEHS/DNTP/NICEATM, Research Triangle Park, Durham, NC
关键词
physiologically-based pharmacokinetic model; in vitro to in vivo extrapolation; risk assessment; computational modeling methods; hazard screening; new approach methodology; EXPOSURE; CHEMICALS; RISK;
D O I
10.3389/fphar.2022.864742
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Regulatory toxicology testing has traditionally relied on in vivo methods to inform decision-making. However, scientific, practical, and ethical considerations have led to an increased interest in the use of in vitro and in silico methods to fill data gaps. While in vitro experiments have the advantage of rapid application across large chemical sets, interpretation of data coming from these non-animal methods can be challenging due to the mechanistic nature of many assays. In vitro to in vivo extrapolation (IVIVE) has emerged as a computational tool to help facilitate this task. Specifically, IVIVE uses physiologically based pharmacokinetic (PBPK) models to estimate tissue-level chemical concentrations based on various dosing parameters. This approach is used to estimate the administered dose needed to achieve in vitro bioactivity concentrations within the body. IVIVE results can be useful to inform on metrics such as margin of exposure or to prioritize potential chemicals of concern, but the PBPK models used in this approach have extensive data requirements. Thus, access to input parameters, as well as the technical requirements of applying and interpreting models, has limited the use of IVIVE as a routine part of in vitro testing. As interest in using non-animal methods for regulatory and research contexts continues to grow, our perspective is that access to computational support tools for PBPK modeling and IVIVE will be essential for facilitating broader application and acceptance of these techniques, as well as for encouraging the most scientifically sound interpretation of in vitro results. We highlight recent developments in two open-access computational support tools for PBPK modeling and IVIVE accessible via the Integrated Chemical Environment (https://ice.ntp.niehs.nih.gov/), demonstrate the types of insights these tools can provide, and discuss how these analyses may inform in vitro-based decision making.
引用
收藏
页数:8
相关论文
共 46 条
[1]   Application of new approach methodologies: ICE tools to support chemical evaluations [J].
Abedini, Jaleh ;
Cook, Bethany ;
Bell, Shannon ;
Chang, Xiaoqing ;
Choksi, Neepa ;
Daniel, Amber B. ;
Hines, David ;
Karmaus, Agnes L. ;
Mansouri, Kamel ;
Mcafee, Eric ;
Phillips, Jason ;
Rooney, John ;
Sprankle, Catherine ;
Allen, David ;
Casey, Warren ;
Kleinstreuer, Nicole .
COMPUTATIONAL TOXICOLOGY, 2021, 20
[2]  
[Anonymous], 2015, Fed. Regist, V80, P35350
[3]  
[Anonymous], GUID IND POP PHARM
[4]   An FDA/CDER perspective on nonclinical testing strategies: Classical toxicology approaches and new approach methodologies (NAMs) [J].
Avila, Amy M. ;
Bebenek, Ilona ;
Bonzo, Jessica A. ;
Bourcier, Todd ;
Bruno, Karen L. Davis ;
Carlson, David B. ;
Dubinion, John ;
Elayan, Ikram ;
Harrouk, Wafa ;
Lee, Shwu-Luan ;
Mendrick, Donna L. ;
Merrill, Jill C. ;
Peretz, Jackye ;
Place, Emily ;
Saulnier, Muriel ;
Wange, Ronald L. ;
Yao, Jia ;
Zhao, Dong ;
Brown, Paul C. .
REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2020, 114
[5]   An integrated chemical environment with tools for chemical safety testing [J].
Bell, Shannon ;
Abedini, Jaleh ;
Ceger, Patricia ;
Chang, Xiaoqing ;
Cook, Bethany ;
Karmaus, Agnes L. ;
Lea, Isabel ;
Mansouri, Kamel ;
Phillips, Jason ;
McAfee, Eric ;
Rai, Ruhi ;
Rooney, John ;
Sprankle, Catherine ;
Tandon, Arpit ;
Allen, David ;
Casey, Warren ;
Kleinstreuer, Nicole .
TOXICOLOGY IN VITRO, 2020, 67
[6]   High-throughput PBTK models for in vitro to in vivo extrapolation [J].
Breen, Miyuki ;
Ring, Caroline L. ;
Kreutz, Anna ;
Goldsmith, Michael-Rock ;
Wambaugh, John F. .
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2021, 17 (08) :903-921
[7]  
BusinessKorea, 2024, KIC to deploy $5 billion for overseas M&A, establishing strategic investment committee, DOI [10.22427/NTP-ICCVAM-ROADMAP2018, DOI 10.22427/NTP-ICCVAM-ROADMAP2018]
[8]   Reducing the need for animal testing while increasing efficiency in a pesticide regulatory setting: Lessons from the EPA Office of Pesticide Programs' Hazard and Science Policy Council [J].
Craig, Evisabel ;
Lowe, Kelly ;
Akerman, Gregory ;
Dawson, Jeffrey ;
May, Brenda ;
Reaves, Elissa ;
Lowit, Anna .
REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2019, 108
[9]   Towards grouping concepts based on new approach methodologies in chemical hazard assessment: the read-across approach of the EU-ToxRisk project [J].
Escher, Sylvia E. ;
Kamp, Hennicke ;
Bennekou, Susanne H. ;
Bitsch, Annette ;
Fisher, Ciaran ;
Graepel, Rabea ;
Hengstler, Jan G. ;
Herzler, Matthias ;
Knight, Derek ;
Leist, Marcel ;
Norinder, Ulf ;
Ouedraogo, Gladys ;
Pastor, Manuel ;
Stuard, Sharon ;
White, Andrew ;
Zdrazil, Barbara ;
van de Water, Bob ;
Kroese, Dinant .
ARCHIVES OF TOXICOLOGY, 2019, 93 (12) :3643-3667
[10]  
FDA, 2018, PHYS BAS PHARM AN FO